Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 2/13/14  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Wolfram E. Samlowski

Wrong Dr. Wolfram E. Samlowski?

Physician

Local Address: Las Vegas, Nevada, United States
Comprehensive Cancer Centers of Nevada (Affiliate of US Oncology)
 
Background

Employment History

Board Memberships and Affiliations

Education

  • MD
  • medical degree
    Ohio State University
  • bachelor
    Ohio State University
  • M.D.
  • M.D. FACP
  • medical degree
    the Ohio State University
  • bachelor
    the Ohio State University
49 Total References
Web References
Wolfram Samlowski, MD, FACP - Comprehensive Cancer Centers of Nevada
www.cccnevada.com, 29 Nov 2012 [cached]
Wolfram Samlowski, MD, FACP
...
Wolfram Samlowski, MD, FACP
...
Home>Our Physicians> Wolfram Samlowski, MD, FACP
...
WOLFRAM SAMLOWSKI, MD, FACP
EDUCATION Dr. Samlowski earned his bachelor's and medical degree from Ohio State University in Columbus, Ohio. He completed his internal medicine residency at Wayne State University in Detroit, and his hematology oncology fellowship at the University of Utah in Salt Lake City.
AREAS OF SPECIAL INTEREST Melanoma and Renal Cancer
EXPERIENCE Prior to joining CCCN, Dr. Samlowski served as director of Translational Research, Multidisciplinary Melanoma program at the Huntsman Cancer Institute. He was professor of Oncology and adjunct professor of pathology and dermatology at the University of Utah, in Salt Lake City, where he worked from 1984 to 2007. In 2007, he joined the Nevada Cancer Institute as Chief, Section of Melanoma, Renal Cancer and Immunotherapy. He also was appointed professor of oncology. Dr. Samlowski has a teaching appointment as Clinical Professor at the University of Nevada, Reno.
PERSONAL Dr. Samlowski and his wife Suzanne recently celebrated their 30th anniversary.
...
Wolfram Samlowski, MD, FACP
AACI Update / July 2008
www.aaci-cancer.org, 1 July 2008 [cached]
"This is a groundbreaking trial so the level of excitement is very high," said Dr. Wolfram Samlowski, NVCI chief, Section of Melanoma, Renal Cancer and Immunotherapy. The therapy is given intravenously. more...
News & Events - Nevada Cancer Institute
www.nevadacancerinstitute.org, 13 July 2009 [cached]
Dr. Wolfram Samlowski Sponsored by Salt Lake City-based Myriad Pharmaceuticals Inc., the treatment, referred to as MPC-3100, is an investigational oral drug currently being studied in qualifying patients with untreatable or relapsed cancer. Wolfram Samlowski, M.D., NVCI head of the Section of Melanoma, Renal Cancer and Immunotherapy, is the principal investigator for the trial conducted at the Institute.
...
"This is another example of access to novel therapies that we can offer to patients in Nevada that are not yet widely available," Dr. Samlowski said.
Our Physicians
www.huntsmancancerinstitute.org, 8 Sept 2006 [cached]
Wolfram E. Samlowski, MD
Professor, Department of Oncology
Wolfram Samlowski, MD, an investigator at Huntsman Cancer Institute and professor of oncology at the University of Utah School of Medicine, sees patients with a variety of cancers.He is also involved in translational researchas and treatments derived from laboratory experiments into actual cancer treatments for patients.He is principal investigator of the University of Utah Immunotherapy Program, which includes trials of interleukin-2 (IL-2) and vaccines.IL-2 is a cancer treatment for melanoma and kidney cancer.
Samlowski was institutional Principal Investigator for the Southwest Oncology Group for 13 years and was a member of the Board of Governors.He continues to be an active member of the Melanoma and Genitourinary Cancer Committees.He is a member of the National Comprehensive Cancer Network Practice Guidelines Committee for melanoma and renal carcinoma.
Samlowski received his BA and MD from Ohio State University.He completed a residency in internal medicine at Wayne State University in 1980, and a clinical fellowship in hematology/oncology at the University of Utah School of Medicine in 1984.He has been a member of the University of Utah faculty since 1981.
MacroMed Inc. - DRUG DELIVERY AND FORMULATIONS COMPANY
www.macromed.com, 24 Sept 2004 [cached]
Wolfram Samlowski, M.D., University of Utah Medical School and Huntsman Cancer Institute.
Dr. Wolfram Samlowski, an investigator at Huntsman Cancer Institute and Professor of Oncology at the University of Utah School of Medicine, predominantly sees patients with kidney cancer and melanoma.He is also involved in translational research - the development of new ideas and treatments derived from laboratory experiments into actual cancer treatments for patients.He is principal investigator of the University of Utah Cancer Immunotherapy Program, which includes trials of interleukin-2 (IL-2) and vaccines.IL-2 is a cancer treatment for melanoma and kidney cancer.Dr. Samlowski is also principal investigator for the Southwest Oncology Group, where he is an active member of the Melanoma Committee and Board of Governors.He is a member of the National Comprehensive Cancer Network (NCCN) Practice Guidelines Committee for melanoma and renal carcinoma.He has been a member of the University of Utah faculty since 1984.
Other People with the name "Samlowski":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304